In a Nutshell:

As part of our portfolio management, we need to continually review which products add greatest value and what we do with those that aren’t living up to expectation or no longer add value?.

In particular: we need to consider:

  • new products

  • products that are under development

  • products that are under management.

For products that are becoming priority items in our product backlog, we need to ask: Are we confident that the customer will derive the level of value expected from this product? And are the highest value products being prioritised?

For products that are under development, we need to ask: Are our customers deriving the level of value they expected from our products? And what adjustments need to be made to address any imbalance?

For products that are under management, we need to ask: Is the product still adding value in line with current investment? And what decisions do we need to make in terms of continued investment?